FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Unichem Pharmaceuticals Clonidine Hydrochloride Tablets Recall

Clonidine Hydrochloride Tablets, USP 0

UNICHEM PHARMACEUTICALS USA INC · East Brunswick, NJ

Risk level
Class III
Reported by FDA
Feb 12, 2020
Recall ID
D-0829-2020
Check your lot numberHow we source this data

Summary

Unichem Pharmaceuticals recalled Clonidine Hydrochloride Tablets starting Jan 29, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0829-2020 on Feb 12, 2020. Reason: Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label. Status: Terminated.

Why it was recalled

Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.

Product description

Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816. NDC 29300-135-01

Lot numbers, UPCs & expiration codes

Lot Numbers: GCLL18108, GCLL18109, GCLL18110 - EXP 10/31/2020; GCLL19003 EXP 12/31/2020

Where it was sold

Distributed Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0829-2020
Classification
Class III
Status
Terminated
Recall initiated
Jan 29, 2020
FDA report date
Feb 12, 2020
Quantity
19161600 units
Recall type
Voluntary: Firm initiated
Recalling firm
UNICHEM PHARMACEUTICALS USA INC

Original FDA data

Every field from FDA enforcement report D-0829-2020, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
84836
Address
1 Tower Center Blvd Ste 2200
Code information
Lot Numbers: GCLL18108, GCLL18109, GCLL18110 - EXP 10/31/2020; GCLL19003 EXP 12/31/2020
Postal code
08816-1145
Report date
Feb 12, 2020
Product type
Drugs
Recall number
D-0829-2020
Classification
Class III
Recalling firm
UNICHEM PHARMACEUTICALS USA INC
Product quantity
19161600 units
Termination date
Jan 8, 2021
Reason for recall
Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816. NDC 29300-135-01
Distribution pattern
Distributed Nationwide in the US
Recall initiation date
Jan 29, 2020
Initial firm notification
Letter
Center classification date
Feb 6, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0829-2020, published Feb 12, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls